Please login to the form below

Not currently logged in
Email:
Password:

Phil Golz appointed commercial director at HealthUnlocked

Moves from ViiV Healthcare to join the socialnetwork for health

Health Unlocked Phil GolzHealth social network HealthUnlocked has appointed Phil Golz to the newly-created role of commercial director.

He joins the company from ViiV Healthcare, where he was executive director, and prior to that he served as head of commercial innovation at GlaxoSmithKline.

In his new role Golz will will be responsible for developing HealthUnlocked's commercial strategy and operations as part of a drive to accelerate its growth and create additional value for members and visitors.

Phil Golz said: "I'm absolutely thrilled to be joining HealthUnlocked at such an exciting time in their evolution. With its advanced technology and relentless focus on creating value for patients, I believe HealthUnlocked has great potential to transform healthcare and I look forward to helping them achieve this goal.

Formed in 2010, HealthUnlocked claims the title of the world's largest social network for health with more than 320,000 registered users who account for over 3.5 million visits to the site each month.

Jorge Armanet, CEO of HealthUnlocked, said: "Phil brings a great depth of knowledge and experience in all areas and angles of healthcare and an energy and fresh views that we are delighted to welcome into our team.

“It's an incredibly exciting time for our company whilst we are moving beyond the peer-to-peer support into a much more comprehensive set of patient services and we look forward to working with a broad range of healthcare players.

28th September 2015

From: Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics